Among these, CD133/prominin-1 is a cell-surface molecule thought to be a stem cell marker for multiple cancer types, including CNS, colon, hepatocellular, pancreatic, prostate, and renal cancer [51]. This evidence concerns the gene PROM1 and renal carcinoma.